Clinical Trial Update: WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating WP1066 with radiation therapy for newly diagnosed glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• WP1066

Snippet

Sponsor: Northwestern University | Conditions: Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma | Phase 2 | Status: RECRUITING